Experts at the European Medicines Agency are preparing to present Tuesday the conclusions of their investigation into possible links between the J&J COVID-19 vaccine and very rare cases of unusual clotting disorders detected in the U.S.
Experts at the European Medicines Agency are preparing to present Tuesday the conclusions of their investigation into possible links between the J&J COVID-19 vaccine and very rare cases of unusual clotting disorders detected in the U.S.